Epidemiology of gout and chondrocalcinosis
Abstract Views: 1045
PDF: 1453
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- S. Stisi, P. Sarzi-Puttini, M. Benucci, G. Biasi, S. Bellissimo, R. Talotta, F. Atzeni, RETRACTED - Pain in systemic sclerosis , Reumatismo: Vol. 66 No. 1 (2014)
- N. Ughi, G.D. Sebastiani, R. Gerli, C. Salvarani, S. Parisi, A. Ariani, I. Prevete, M. Manara, F. Rumi, C.A. Scirè, A. Bortoluzzi, Reply to the Letter to the Editor: The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica , Reumatismo: Vol. 72 No. 2 (2020)
- A. Ariani, M. Manara, A. Fioravanti, F. Iannone, F. Salaffi, N. Ughi, I. Prevete, A. Bortoluzzi, S. Parisi, C.A. Scirè, The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of knee, hip and hand osteoarthritis , Reumatismo: Vol. 71 No. S1 (2019)
- R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni, Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study , Reumatismo: Vol. 68 No. 2 (2016)
- C.L. Teh, Y.K. Cheong, S.A. Wan, G.R. Ling, Treat-to-target (T2T) of serum urate (SUA) in gout: a clinical audit in real-world gout patients , Reumatismo: Vol. 71 No. 3 (2019)
- G. Zampogna, R. Andracco, M. Parodi, M.A. Cimmino, Clinical features of gout in a cohort of Italian patients , Reumatismo: Vol. 61 No. 1 (2009)
- L. De Filippis, S. Gulli, A. Caliri, C. Romano, F. Munaò, G. Trimarchi, D. La Torre, C. Fichera, A. Pappalardo, G. Triolo, M. Gallo, G. Valentini, G. Bagnato, Gruppo OASIS (Osteoarthritis South Italy Study), Epidemiology and risk factors in osteoarthritis: literature review data from “OASIS” study , Reumatismo: Vol. 56 No. 3 (2004)
- F. Viazzi, G. Leoncini, R. Pontremoli, Cardiovascular and renal effects of hyperuricaemia and gout , Reumatismo: Vol. 63 No. 4 (2011): Special issue • Microcrystalline Arthritis
- M.A. Cimmino, A. Zampogna, S. Murroni, S. Baruffi, G. Alessio, T. Maio, G.S. Mela, Prevalence studies in rheumatology: the methodology of the Chiavari study , Reumatismo: Vol. 54 No. 1 (2002)
- A. Alunno, O. Bistoni, F. Pratesi, F. Topini, I. Puxeddu, V. Valentini, G. Cafaro, E. Bartoloni, P. Migliorini, R. Gerli, Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: a pilot study , Reumatismo: Vol. 70 No. 2 (2018)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.